This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brodde, O.-E. Articles by Insel, P. A. Search for Related Content PubMed PubMed Citation Articles by Brodde, O.-E. Articles by Insel, P. A. Related Collections Clinical genetics Receptor pharmacology Cell signalling/signal transduction

(Circulation. 2001;103:1048.)
© 2001 American Heart Association, Inc.

Brief Rapid Communications

Blunted Cardiac Responses to Receptor Activation in Subjects With Thr164Ile ß₂-Adrenoceptors

Otto-Erich Brodde, PhD; Rainer Büscher, MD; Ralph Tellkamp, MD; Joachim Radke, MD; Stefan Dhein, MD; Paul A. Insel, MD

From the Departments of Pharmacology (O.-E.B., S.D.) and Anesthesiology (R.T., J.R.), University of Halle, Germany; the Department of Pediatric Nephrology (R.B.), University of Essen, Germany; and the Department of Pharmacology (P.A.I.), University of California at San Diego, La Jolla, Calif.

Correspondence to Paul A. Insel, MD, Department of Pharmacology, University of California at San Diego, 9500 Gilman Drive, MC 0636, La Jolla, CA 92093-0636. E-mail pinsel{at}ucsd.edu

Background—Recent evidence indicates that certain genotypes of ß₂-adrenoceptors (AR) may indicate an increased risk of cardiovascular disease or an increased rate of disease progression. Of particular importance, the Thr164Ile polymorphism, which is found in 4% of humans, shows decreased receptor signaling, blunted cardiac response when expressed in transgenic mice, and is associated with a decreased survival rate in patients with congestive heart failure.

Methods and Results—In this study, we compared functional activity, ie, chronotropic (heart rate increases) and inotropic (duration of the electromechanical systole) responses to intravenously administered terbutaline, in 6 subjects (4 women and 2 men) who were heterozygous for Thr164Ile with the responses in 12 volunteers (6 women and 6 men) who were homozygous for wild-type (WT) ß₂-AR (ie, Arg16, Gln27, and Thr164). The ß₂AR polymorphism significantly affected the dose-response curves for terbutaline-induced inotropic and chronotropic responses: compared with WT individuals, subjects with the Thr164Ile receptor had substantial blunting in maximal increases in heart rate (WT, 29.7±3.9 beats/min; Ile164, 20.7±1.9 beats/min; P=0.016) and a shortening of the duration of electromechanical systole (WT, 51.9±4.5 ms; Ile164, 37.9±4.6 ms; P=0.02).

Conclusions—These data show that humans with the Ile164 genotype show blunted cardiac ß₂-AR responsiveness, which may help explain the decreased survival of patients with this genotype in the setting of congestive heart failure.

Key Words: receptors, adrenergic, beta • myocardial contraction • heart rate • terbutaline • genetics

This article has been cited by other articles:

				E. Barbato, M. Penicka, L. Delrue, F. Van Durme, B. De Bruyne, M. Goethals, W. Wijns, M. Vanderheyden, and J. Bartunek Thr164Ile polymorphism of {beta}2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy Heart, July 1, 2007; 93(7): 856 - 861. [Abstract] [Full Text] [PDF]

				I. P. Hall and I. Sayers Pharmacogenetics and asthma: false hope or new dawn? Eur. Respir. J., June 1, 2007; 29(6): 1239 - 1245. [Abstract] [Full Text] [PDF]

				S. L. Kirstein and P. A. Insel Autonomic Nervous System Pharmacogenomics: A Progress Report Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52. [Abstract] [Full Text] [PDF]

				M. J. Lohse, S. Engelhardt, and T. Eschenhagen What Is the Role of {beta}-Adrenergic Signaling in Heart Failure? Circ. Res., November 14, 2003; 93(10): 896 - 906. [Abstract] [Full Text] [PDF]

				H. Bruck, K. Leineweber, A. Ulrich, J. Radke, G. Heusch, T. Philipp, and O.-E. Brodde Thr164Ile polymorphism of the human {beta}2-adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2034 - H2038. [Abstract] [Full Text] [PDF]

				D. H. Au, E. M. Udris, V. S. Fan, J. R. Curtis, M. B. McDonell, and S. D. Fihn Risk of Mortality and Heart Failure Exacerbations Associated With Inhaled {beta}-Adrenoceptor Agonists Among Patients With Known Left Ventricular Systolic Dysfunction Chest, June 1, 2003; 123(6): 1964 - 1969. [Abstract] [Full Text] [PDF]

				A. Chruscinski, M. E. Brede, L. Meinel, M. J. Lohse, B. K. Kobilka, and L. Hein Differential Distribution of beta -Adrenergic Receptor Subtypes in Blood Vessels of Knockout Mice Lacking beta 1- or beta 2-Adrenergic Receptors Mol. Pharmacol., November 1, 2001; 60(5): 955 - 962. [Abstract] [Full Text] [PDF]

				W. Kiowski The endothelin-type-A receptor in dilated cardiomyopathy: another key player? Eur. Heart J., October 2, 2001; 22(20): 1849 - 1851. [PDF]

				R. D. Feldman Adrenergic Receptor Polymorphisms and Cardiac Function (and Dysfunction) : A Failure to Communicate? Circulation, February 27, 2001; 103(8): 1042 - 1043. [Full Text] [PDF]